
Researchers said the price in this drug ad had a profound impact on the way people thought about the drug. Researchers made up the name, Mayzerium, as a drug for diabetes as part of the study.

Pharmaceutical companies have lobbied to have modifiers, like in this ad used in the study. When the modifier was added to the high-price drug, the study participants were more interested.

The study found that low prices, like this one, did not negatively affect people's opinions of the drug.

The modifier on the lower-priced drug did not significantly change people's opinions, the study found.

The fifth ad was a control advertisement with no price listed.


